Patents by Inventor Dan J. Raz

Dan J. Raz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTIGENE PROGNOSTIC ASSAY FOR LUNG CANCER
    Publication number: 20250075274
    Abstract: The present invention provides methods for providing a prognosis for lung adenocarcinoma, using a panel of eight molecular markers that are differentially expressed in lung adenocarcinoma.
    Type: Application
    Filed: April 24, 2024
    Publication date: March 6, 2025
    Inventors: David M. JABLONS, Dan J. RAZ, Biao HE
  • MULTIGENE PROGNOSTIC ASSAY FOR LUNG CANCER
    Publication number: 20220195532
    Abstract: The present invention provides methods for providing a prognosis for lung adenocarcinoma, using a panel of eight molecular markers that are differentially expressed in lung adenocarcinoma.
    Type: Application
    Filed: December 3, 2021
    Publication date: June 23, 2022
    Inventors: David M. JABLONS, Dan J. RAZ, Biao HE
  • MULTIGENE PROGNOSTIC ASSAY FOR LUNG CANCER
    Publication number: 20200377957
    Abstract: The present invention provides methods for providing a prognosis for lung adenocarcinoma, using a panel of eight molecular markers that are differentially expressed in lung adenocarcinoma.
    Type: Application
    Filed: December 23, 2019
    Publication date: December 3, 2020
    Inventors: David M. JABLONS, Dan J. RAZ, Biao HE
  • MULTIGENE PROGNOSTIC ASSAY FOR LUNG CANCER
    Publication number: 20180002761
    Abstract: The present invention provides methods for providing a prognosis for lung adenocarcinoma, using a panel of eight molecular markers that are differentially expressed in lung adenocarcinoma.
    Type: Application
    Filed: March 8, 2017
    Publication date: January 4, 2018
    Inventors: David M. JABLONS, Dan J. RAZ, Biao HE
  • MULTIGENE PROGNOSTIC ASSAY FOR LUNG CANCER
    Publication number: 20100240035
    Abstract: The present invention provides methods for providing a prognosis for lung adenocarcinoma, using a panel of eight molecular markers that are differentially expressed in lung adenocarcinoma.
    Type: Application
    Filed: May 30, 2008
    Publication date: September 23, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: David M. Jablons, Dan J. Raz